BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20926881)

  • 1. Epstein-Barr virus, lymphoma risk and the potential role of HIV infection in IBD patients undergoing immunosuppression.
    Weinstock DM
    Dig Dis; 2010; 28(3):519-24. PubMed ID: 20926881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.
    Sokol H; Beaugerie L
    Gut; 2009 Oct; 58(10):1427-36. PubMed ID: 19749141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
    Kwon JH; Farrell RJ
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):169-78. PubMed ID: 15979323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory bowel diseases and lymphoma].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas.
    Wong NA; Herbst H; Herrmann K; Kirchner T; Krajewski AS; Moorghen M; Niedobitek F; Rooney N; Shepherd NA; Niedobitek G
    J Pathol; 2003 Oct; 201(2):312-8. PubMed ID: 14517849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented?
    Beaugerie L
    Dig Dis; 2012; 30(4):415-9. PubMed ID: 22796808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.
    Beaugerie L; Sokol H; Seksik P
    Dig Dis; 2009; 27(3):375-81. PubMed ID: 19786768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphoproliferative disorders in an inflammatory bowel disease unit].
    Van Domselaar M; López San Román A; Bastos Oreiro M; Garrido Gómez E
    Gastroenterol Hepatol; 2010 Jan; 33(1):12-6. PubMed ID: 19889478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viruses and lymphoma/leukaemia.
    Jarrett RF
    J Pathol; 2006 Jan; 208(2):176-86. PubMed ID: 16362996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV Status and Thiopurine Use in Pediatric IBD.
    Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma.
    Brumbaugh J; Baldwin JC; Stinson EB; Oyer PE; Jamieson SW; Bieber CP; Henle W; Shumway NE
    J Heart Transplant; 1985 May; 4(3):307-11. PubMed ID: 3039097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the links between Epstein-Barr virus, lymphoma, and tumor necrosis factor antagonism in rheumatoid arthritis?
    Balandraud N; Roudier J; Roudier C
    Semin Arthritis Rheum; 2005 Apr; 34(5 Suppl1):31-3. PubMed ID: 15852253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection.
    Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M
    HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated lymphomas.
    Gandhi MK
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central-nervous-system lymphoma related to Epstein-Barr virus.
    Hochberg FH; Miller G; Schooley RT; Hirsch MS; Feorino P; Henle W
    N Engl J Med; 1983 Sep; 309(13):745-8. PubMed ID: 6310394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.